zimmytws
SPAC SEP Acquisition Corp. (NASDAQ:SEPA) shareholders have approved a planned merger with wound care products provider Sanuwave Health (OTCQB:SNWV).
The merger will result in Sanuwave’s shares being uplisted to Nasdaq. The shares are expected to trade under the same symbol, SNWV.
SEP disclosed the vote in an SEC filing, but didn’t indicate when the closing will take place.
SEP and Sanuwave announced plans to merge in August, with the deal estimating the enterprise value of the combined company at $127.5M.
Sanuwave has two FDA-approved medical devices for the treatment of wounds. Its lead product, UltraMist, has nationwide schedule 1 reimbursement by the Centers for Medicare and Medicaid Services.
More on SEP Acquisition Corp., SANUWAVE Health, etc.
Source link
